hypertrophic pyloric stenosis

Hypertrophic pyloric stenosis occurs in about 3/1000 live births.

It is used to treat hypertrophic pyloric stenosis.

Infants exposed to erythromycin are at increased risk for developing hypertrophic pyloric stenosis, especially when the drug is taken around two weeks of life.

Erythromycin used for feeding intolerance in young infants has not been associated with hypertrophic pyloric stenosis.

Infantile hypertrophic pyloric stenosis was first fully described by Harald Hirschsprung in 1888.

The efficacy of laparoscopy is inferior to open surgery in situations such as pyloromyotomy for infantile hypertrophic pyloric stenosis.

Neonatal jaundice may develop in the presence of sepsis, hypoxia, hypoglycemia, hypothyroidism, hypertrophic pyloric stenosis, galactosemia, fructosemia, and so on.

It is a classic symptom of infantile hypertrophic pyloric stenosis, in which it typically follows feeding and can be so forceful that some material exits through the nose.

Erythromycin should be used with caution in neonates; hypertrophic pyloric stenosis and life-threatening episodes of ventricular tachycardia associated with prolonged QTc interval have been reported.

Pyloric stenosis (or infantile hypertrophic pyloric stenosis or pylorostenosis) is a condition that causes severe projectile non-bilious vomiting in the first few months of life.

On 3 February 1910 he performed the first pyloromyotomy, a surgery to correct congenital hypertrophic pyloric stenosis, the congenital narrowing of the path between the stomach and the intestines in infants.

The risk of two disorders, hypertrophic pyloric stenosis, a narrowing of the stomach, and patent ductus arteriosis, a heart defect, declines steadily with age, she said, while a third defect, a dislocatable hip, follows a bell-shaped curve, rising in frequency until the age of 30 and then decreasing.